PIP4K2C
| Official symbol: | PIP4K2C |
| Full name: | phosphatidylinositol-5-phosphate 4-kinase type 2 gamma |
| Location: | 12q13.3 |
| Also known as: | FLJ22055, PIP5K2C |
| Entrez ID: | 79837 |
| Ensembl ID: | ENSG00000166908 |
| Summary: | |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.00 | | Gscore (Del): | 0.00 |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
| Total fusion occurrence: | 9 |
|
|
| Fusions detected in 5 cancer type(s) |
|
| |
|
|
|
| Functional class: | Kinase |
| JensenLab PubMed score: | 2.41 (Percentile rank: 18.44%) |
| PubTator score: | 31.31 (Percentile rank: 60.21%) |
| Target development/druggability level: | TchemThese targets have activities in ChEMBL or DrugCentral that satisfy the activity thresholds detailed below. |
| Tractability (small molecule): | Discovery PrecedenceTargets with ligands; Targets with crystal structures with ligands |
| Tractability (antibody): | |
